Regulatory Comments Archives

340B and Drug Pricing

Association Responds to Eli Lilly’s Targeted 340B Pricing Suspension

June 23, 2026

Medicare

Association Responds to FY 2027 IPPS Proposed Rule

June 12, 2026

Health IT

Association Comments on Interoperability Standards and Prior Authorization for Drugs

June 9, 2026

340B and Drug Pricing

Association Responds to 340B Rebate Model Information Collection Request

April 28, 2026

Medicaid

Association Comments on Accounting Standards Affecting Supplemental Payments

April 28, 2026

340B and Drug Pricing

Association Responds to 340B Rebate Model Request for Information

April 21, 2026

New Payment Methods

Association Comments on CMS Domestic Procurement Proposals

March 30, 2026

Medicaid

Association Comments on CRUSH RFI

March 30, 2026

Health Care Reform

Association Comments on Non-Network Qualified Health Plans

March 16, 2026

Medicaid

Association Urges CMS to Streamline Hardship, Medical Frailty Exemptions in Medicaid Work Requirements Implementation

March 12, 2026

340B and Drug Pricing

Association to HRSA: Reject Novo Nordisk Claims Reporting Changes

March 10, 2026

340B and Drug Pricing

Association Highlights Improper Maximum Fair Price Denials

March 6, 2026

Health Care Reform

Association Comments on 2027 Marketplace Proposed Rule

March 4, 2026

Health IT

Association Comments on HHS AI Request for Information

February 24, 2026

340B and Drug Pricing

Association Urges HRSA to Extend Rebate Model RFI Comment Period

February 20, 2026

Medicaid

Association Comments on CMS Gender Transition Care Rules

February 18, 2026

Medicare

Association Comments on Proposed MA Rule

January 27, 2026

Medicare

Association Urges MedPAC to Consider Alternatives to ‘Flawed’ Safety-Net Index

January 14, 2026

Medicaid

Association Comments on Public Charge Proposed Rule

December 17, 2025

Medicaid

Association Urges CMS to Align SDP, Provider Tax Rulemaking with Congressional Intent

December 17, 2025

340B and Drug Pricing

America’s Essential Hospitals Requests Rebate Model Details from HRSA

December 2, 2025

Health Care Reform

Association Comments on CY 2026 PFS Proposed Rule

September 15, 2025

340B and Drug Pricing

Association Urges HRSA to Rescind Proposed 340B Rebate Pilot

September 8, 2025

Medicaid

Association Comments on Medicaid Tax Proposed Rule

July 15, 2025

Members:

Two Timely Updates on the 340B Drug Pricing Program

Regulatory Comments

Filter By:

Association Responds to Eli Lilly’s Targeted 340B Pricing Suspension

Association Responds to FY 2027 IPPS Proposed Rule

Association Comments on Interoperability Standards and Prior Authorization for Drugs

Association Responds to 340B Rebate Model Information Collection Request

Association Comments on Accounting Standards Affecting Supplemental Payments

Association Responds to 340B Rebate Model Request for Information

Association Comments on CMS Domestic Procurement Proposals

Association Comments on CRUSH RFI

Association Comments on Non-Network Qualified Health Plans

Association Urges CMS to Streamline Hardship, Medical Frailty Exemptions in Medicaid Work Requirements Implementation

Association to HRSA: Reject Novo Nordisk Claims Reporting Changes

Association Highlights Improper Maximum Fair Price Denials

Association Comments on 2027 Marketplace Proposed Rule

Association Comments on HHS AI Request for Information

Association Urges HRSA to Extend Rebate Model RFI Comment Period

Association Comments on CMS Gender Transition Care Rules

Association Comments on Proposed MA Rule

Association Urges MedPAC to Consider Alternatives to ‘Flawed’ Safety-Net Index

Association Comments on Public Charge Proposed Rule

Association Urges CMS to Align SDP, Provider Tax Rulemaking with Congressional Intent

America’s Essential Hospitals Requests Rebate Model Details from HRSA

Association Comments on CY 2026 PFS Proposed Rule

Association Urges HRSA to Rescind Proposed 340B Rebate Pilot

Association Comments on Medicaid Tax Proposed Rule